Showing 61 - 80 results of 378 for search '"hepatitis"', query time: 0.05s Refine Results
  1. 61
  2. 62

    Co-dynamics of hepatitis B and C viruses under the influence of CTL immunity by A.M. Elaiw, GH.S. Alsaadi, A.A. Raezah, A.D. Hobiny

    Published 2025-04-01
    “…Understanding the cytotoxic T lymphocyte (CTL) immune response against hepatitis B virus (HBV) and hepatitis C virus (HCV) infections is crucial, as these infections can lead to liver cirrhosis and cancer. …”
    Get full text
    Article
  3. 63
  4. 64
  5. 65

    PLIN5 contributes to lipophagy of hepatic stellate cells induced by inorganic arsenic by Haomiao Li, Xuri Xie, Tianming Qiu, Jingyuan Zhang, Jie Bai, Guang Yang, Ningning Wang, Xiaofeng Yao, Xiance Sun

    Published 2025-01-01
    “…Arsenic exposure triggers the activation of hepatic stellate cells (HSCs), resulting in liver fibrosis (LF). …”
    Get full text
    Article
  6. 66
  7. 67
  8. 68
  9. 69

    Efficacy of daclatasvir and asunaprevir for viral hepatitis С in two donor lung recipients by D. T. Abdurakhmanov, Ye. . Sidorova, I. N. Tikhonov, N. A. Mukhin, V. T. Ivashkin

    Published 2018-08-01
    “…To estimate efficacy and safety of direct antiviral drugs for hepatitis C treatment in donor lung recipients. Key points. …”
    Get full text
    Article
  10. 70
  11. 71
  12. 72
  13. 73

    Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen by Andrew Trigg, Eric Chan, Helen Kitchen, Tom Willgoss, Kai Fai Ho, Renee Pierson, Jane Scott

    Published 2019-02-01
    “…**Background:** Hepatitis C virus (HCV) infection and its treatments are associated with significant symptoms, side effects and impact on patients functioning. …”
    Get full text
    Article
  14. 74

    Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany by Jona T. Stahmeyer, Svenja Schauer, Siegbert Rossol, Hans Heinrich Wedemeyer, Daniel Wirth, Florence Bianic, Christian Krauth

    Published 2013-12-01
    “…**Background:** About 400,000-500,000 people are infected with hepatitis C in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. …”
    Get full text
    Article
  15. 75

    Middle hepatic vein incorporation in live donor liver graft transplantation; implication and safety by Mahmoud Ali Abdi, Tayeb Sabir Kareem, Assad Abidon Hassoun

    Published 2021-08-01
    “…The recipient age (48.5 ± 11.3), male/female 27/13, intensive care unit stay (4.75 ± 3.9), floor stay (7.7 ± 3.7) days, portal vein velocity (63.96 ± 24.65 ml/sec), hepatic artery peak systolic velocity (74.76 ± 32.85) hepatic artery resistive index (0.7 ± 0.15), and triphasic/continuous venous outflow 27/13.   …”
    Get full text
    Article
  16. 76
  17. 77

    Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. by Wangyu Ye, Yuan Ding, Meng Li, Zhihua Tian, Shaoli Wang, Zhen Liu

    Published 2025-01-01
    “…<h4>Background</h4>Drug-induced autoimmune-like hepatitis (DI-ALH) is a potentially life-threatening condition that can lead to acute liver failure and necessitate liver transplantation. …”
    Get full text
    Article
  18. 78
  19. 79
  20. 80